Literature DB >> 6450468

On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.

D Collen.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6450468

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  136 in total

1.  Novel and Innovative Dosing Regimens in Thrombolytic Therapy for Acute Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

Review 2.  Thrombolytic therapy in acute myocardial infarction.

Authors:  U Priglinger; K Huber
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

Review 3.  Molecular basis of thrombolytic therapy.

Authors:  H R Lijnen; D Collen
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

Review 4.  Use of plasminogen activators in venous thrombosis.

Authors:  J Hirsh; A G Turpie
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

5.  Thrombolysis with plasmin: implications for stroke treatment.

Authors:  Victor J Marder; Reza Jahan; Theresa Gruber; Abha Goyal; Vik Arora
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

6.  Tissue-type plasminogen activator in rat adrenal medulla.

Authors:  P Kristensen; D M Hougaard; L S Nielsen; K Danø
Journal:  Histochemistry       Date:  1986

7.  The effect of different exercise intensities on the fibrinolytic system.

Authors:  A B Molz; B Heyduck; H Lill; E Spanuth; L Röcker
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

8.  Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann.

Authors:  J Reinartz; H Näher; H Mai; M D Kramer
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

9.  The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.

Authors:  M D Kramer; J Reinartz
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion.

Authors:  R D Shlansky-Goldberg; A H Matsumoto; G A Baumbach; J B Siegel; R D Raabe; T P Murphy; C Deng; J Ray Dawkins; V J Marder
Journal:  J Thromb Haemost       Date:  2008-04-02       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.